Machine learning enabled subgroup analysis with real-world data to inform better clinical trial design

Jie Xu; Hao Zhang; Hansi Zhang; Jiang Bian; Fei Wang

doi:10.1101/2021.05.11.21257024

Data Availability

The real data analyzed in this article were provided by OneFlorida Clinical Research Consortium and restrictions apply to the availability of these data. Requests for access to the data should be submitted to and approved by OneFlorida Clinical Research Consortium.

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Machine learning enabled subgroup analysis with real-world data to inform better clinical trial design

Data Availability

Subject Area

Citation Manager Formats

Machine learning enabled subgroup analysis with real-world data to inform better clinical trial design

Data Availability

Subject Area

Follow this preprint